Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -23.08% vs 79.31% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 40.00% vs 0.00% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is 19.80% vs 66.48% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 65.41% vs 11.98% in Mar 2025
Compare Balance Sheet Results of Shelter Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
16.61
18.13
-1.52
-8.38%
Share Warrants & Outstandings
Total Reserve
56.05
37.28
18.77
50.35%
Shareholder's Funds
76.63
55.41
21.22
38.30%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.75
4.69
-3.94
-84.01%
Secured Loans
0.00
4.23
-4.23
-100.00%
Unsecured Loans
0.75
0.46
0.29
63.04%
Deferred Tax Assets / Liabilities
-0.00
2.53
-2.53
-100.00%
Other Long Term Liabilities
0.07
0.00
0.07
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.60
7.22
-6.62
-91.69%
Current Liabilities
Trade Payables
1.25
17.65
-16.40
-92.92%
Other Current Liabilities
5.48
4.40
1.08
24.55%
Short Term Borrowings
0.27
10.48
-10.21
-97.42%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
7.00
32.53
-25.53
-78.48%
Total Liabilities
84.23
95.15
-10.92
-11.48%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
9.94
61.88
-51.94
-83.94%
Less: Accumulated Depreciation
2.80
22.72
-19.92
-87.68%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
7.14
39.16
-32.02
-81.77%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
3.68
-3.68
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.68
0.00
0.68
0.00%
Long Term Loans & Advances
21.37
0.00
21.37
0.00%
Other Non Current Assets
0.00
1.04
-1.04
-100.00%
Total Non-Current Assets
29.18
43.88
-14.70
-33.50%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
24.44
14.04
10.40
74.07%
Sundry Debtors
11.81
27.50
-15.69
-57.05%
Cash and Bank
1.08
4.04
-2.96
-73.27%
Other Current Assets
1.33
4.93
-3.60
-73.02%
Short Term Loans and Advances
16.40
0.77
15.63
2,029.87%
Total Current Assets
55.05
51.28
3.77
7.35%
Net Current Assets (Including Current Investments)
48.05
18.75
29.30
156.27%
Total Current Assets Excluding Current Investments
55.05
51.28
3.77
7.35%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
84.23
95.15
-10.92
-11.48%
Contingent Liabilities
3.64
0.00
3.64
0.00%
Total Debt
0.59
15.17
-14.58
-96.11%
Book Value per share (adjusted)
43.18
30.56
12.62
41.30%
Annual - Borrowings
Borrowings 0.80 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -23.08% vs 79.31% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.07 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 40.00% vs 0.00% in Mar 2025
Annual - Fixed Assets
Fixed Assets 7.14 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 19.80% vs 66.48% in Mar 2025
Annual - Investments
Investments 0.68 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 55.05 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 65.41% vs 11.98% in Mar 2025
Footer loading
